132 related articles for article (PubMed ID: 7582157)
1. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
Ariano R; Panzani RC; Chiapella M; Augeri G; Falagiani P
J Investig Allergol Clin Immunol; 1995; 5(3):126-32. PubMed ID: 7582157
[TBL] [Abstract][Full Text] [Related]
2. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
3. Nasal immunotherapy in pollen-sensitive children.
Cserháti E; Mezei G
Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
[TBL] [Abstract][Full Text] [Related]
4. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
5. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
[TBL] [Abstract][Full Text] [Related]
6. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen.
D'Amato G; Lobefalo G; Liccardi G; Cazzola M
Clin Exp Allergy; 1995 Feb; 25(2):141-8. PubMed ID: 7750006
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
Bertoni M; Cosmi F; Bianchi I; Di Berardino L
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study.
Troise C; Voltolini S; Canessa A; Pecora S; Negrini AC
J Investig Allergol Clin Immunol; 1995; 5(1):25-30. PubMed ID: 7551201
[TBL] [Abstract][Full Text] [Related]
10. Specific nasal provocation test with powder allergen.
Salzano FA
Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of topical azelastine in the treatment of allergic rhinitis caused by Parietaria officinalis].
Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
Recenti Prog Med; 1998 Apr; 89(4):177-9. PubMed ID: 9612009
[TBL] [Abstract][Full Text] [Related]
12. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
13. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation.
Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW
Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693
[TBL] [Abstract][Full Text] [Related]
14. Rush sublingual immunotherapy in Parietaria allergic patients.
D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
[TBL] [Abstract][Full Text] [Related]
15. Short-term efficacy of nasal immunotherapy.
Palma-Carlos AG; Santos AS; Pregal A
Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
[TBL] [Abstract][Full Text] [Related]
16. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
18. A multicenter trial of specific local nasal immunotherapy.
Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA
Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
[TBL] [Abstract][Full Text] [Related]
19. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis.
Senna GE; Andri G; Dama AR; Falagiani P; Andri L
Allergol Immunopathol (Madr); 2000; 28(4):238-42. PubMed ID: 11022271
[TBL] [Abstract][Full Text] [Related]
20. The type of sensitizing allergen can affect the evolution of respiratory allergy.
Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
